BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28946474)

  • 1. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
    Kumar S; Randhawa JK
    Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
    Hassani Najafabadi A; Abdouss M; Faghihi S
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction.
    Hosny KM; Aljaeid BM
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1015-22. PubMed ID: 24746063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
    Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
    Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
    Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
    Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
    Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
    Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
    Pradhan M; Singh D; Singh MR
    Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Biomed Nanotechnol; 2010 Dec; 6(6):634-40. PubMed ID: 21361127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticle: A potent vehicle of the kaempferol for brain delivery through the blood-brain barrier in the focal cerebral ischemic rat.
    Ghosh A; Khanam N; Nath D
    Chem Biol Interact; 2024 Jul; 397():111084. PubMed ID: 38823537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
    Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
    Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic Cavitation-Assisted Formulation of Solid Lipid Nanoparticles using Different Stabilizers.
    Kumar R; Singh A; Garg N
    ACS Omega; 2019 Aug; 4(8):13360-13370. PubMed ID: 31460464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.